Clinical Trial

Metformin for Type 2 Diabetes with Chronic Kidney Disease

Study Description

Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease

This is a proposal for a retrospective observational study of the safety of metformin use in patients with chronic kidney disease, compared to other commonly used diabetes drugs. It will be conducted using retrospective data from the New York City CDRN, Medicare administrate files, and New York State Medicaid administrative files, which will be linked and then deidentified prior to analysis.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Metformin

Newly Initiated and regular metformin dosage as prescribed by each patient's medical care provider

Drug - Sulfonylurea

Newly initiated and regular sulfonylurea dosage as prescribed by each patient's medical care provider

Drug - DPP-4 inhibitor

Newly initiated and regular DPP-4 inhibitor dosage as prescribed by each patient's medical care provider

Drug - SGLT2 inhibitor

Newly initiated and regular SGLT2 inhibitor dosage as prescribed by each patient's medical care provider

Drug - GLP1 receptor agonist

Newly initiated and regular GLP1 receptor agonist dosage as prescribed by each patient's medical care provider

Additional Information

Official Study Title

Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease

Clinical Trial ID

NCT03921242

ParticipAid ID

e0RmNb